J&J | تكلفة المبيعات



Cost Of Sales تغيير تاريخ
AbbVie USD 4B 394M 2025-03
Abbott USD 5.27B 834M 2025-06
Amgen USD 2.6B 507M 2025-03
AstraZeneca USD 2.24B 484M 2025-03
Baxter International USD 1.74B 73M 2024-12
Bayer EUR 5.62B 98M 2025-03
Becton, Dickinson and Co. USD 3.02B 82M 2025-03
Biogen USD 629.3M 45.8M 2025-03
Boston Scientific USD 1.88B 409M 2025-06
Bristol-Myers Squibb USD 3.03B 179M 2025-03
CONMED USD 140.09M 7.51M 2025-03
Cooper Companies USD 323.2M 18.7M 2025-04
Dexcom USD 447M 42.8M 2025-03
Edwards Lifesciences USD 344.4M 42.8M 2025-06
Eli Lilly USD 2.22B 179.6M 2025-03
Gilead Sciences USD 1.54B 41M 2025-03
GlaxoSmithKline GBP 1.92B 635M 2025-03
Globus Medical USD 195.4M 68.04M 2025-03
Hologic USD 444.6M 3.3M 2025-03
Indivior 44M 21M 2025-03
Insulet USD 160M 6.6M 2025-03
Integra LifeSciences USD 167.51M 9.29M 2025-03
Intuitive Surgical USD 822.1M 26.4M 2025-06
J&J USD 7.6B 304M 2025-06
Medtronic USD 3.11B 339M 2025-04
Merck USD 2.76B 944M 2025-03
Merit Medical Systems USD 733.32M 551.15M 2025-03
Novartis USD 3.32B 95M 2025-06
Pfizer USD 2.59B 3.06B 2025-03
Regeneron Pharmaceuticals USD 265.5M 299.9M 2025-03
Roche Holding CHF 4.13B 393.5M 2024-12
Sanofi EUR 2.89B 618M 2025-03
Stryker USD 2.12B 118M 2025-03
Tandem Diabetes Care USD 116.02M 9.18M 2025-03
Teva Pharmaceutical Industries USD 1.98B 132M 2025-03
Vertex Pharmaceuticals USD 423.4M 30.8M 2024-12
Zimmer Biomet Holdings USD 586.7M 48.1M 2024-12
Zoetis USD 622M 85M 2025-03


J&J تكلفة المبيعات - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Jul 2025.